Integra LifeSciences (IART) Competitors $14.50 -0.30 (-2.03%) Closing price 04:00 PM EasternExtended Trading$14.54 +0.04 (+0.28%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IART vs. ITGR, ATEC, ATRC, OFIX, ANGO, SRDX, ARAY, RMTI, ABT, and ISRGShould you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), Orthofix Medical (OFIX), AngioDynamics (ANGO), Surmodics (SRDX), Accuray (ARAY), Rockwell Medical (RMTI), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry. Integra LifeSciences vs. Its Competitors Integer Alphatec AtriCure Orthofix Medical AngioDynamics Surmodics Accuray Rockwell Medical Abbott Laboratories Intuitive Surgical Integra LifeSciences (NASDAQ:IART) and Integer (NYSE:ITGR) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership. Do institutionals & insiders believe in IART or ITGR? 84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 3.5% of Integra LifeSciences shares are owned by company insiders. Comparatively, 2.2% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is IART or ITGR more profitable? Integer has a net margin of 4.61% compared to Integra LifeSciences' net margin of -30.87%. Integer's return on equity of 12.27% beat Integra LifeSciences' return on equity.Company Net Margins Return on Equity Return on Assets Integra LifeSciences-30.87% 12.15% 4.32% Integer 4.61%12.27%6.23% Which has more volatility & risk, IART or ITGR? Integra LifeSciences has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. Comparatively, Integer has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Does the media prefer IART or ITGR? In the previous week, Integra LifeSciences had 2 more articles in the media than Integer. MarketBeat recorded 5 mentions for Integra LifeSciences and 3 mentions for Integer. Integer's average media sentiment score of 1.51 beat Integra LifeSciences' score of 0.70 indicating that Integer is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer IART or ITGR? Integra LifeSciences currently has a consensus price target of $18.43, indicating a potential upside of 27.09%. Integer has a consensus price target of $139.57, indicating a potential upside of 32.51%. Given Integer's stronger consensus rating and higher probable upside, analysts clearly believe Integer is more favorable than Integra LifeSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Integra LifeSciences 5 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.70Integer 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.89 Which has stronger valuation and earnings, IART or ITGR? Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntegra LifeSciences$1.61B0.70-$6.94M-$6.53-2.22Integer$1.72B2.15$119.90M$2.2746.40 SummaryInteger beats Integra LifeSciences on 14 of the 17 factors compared between the two stocks. Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IART vs. The Competition Export to ExcelMetricIntegra LifeSciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.15B$7.23B$6.16B$10.58BDividend YieldN/A1.17%5.66%4.69%P/E Ratio-2.2219.2765.0423.37Price / Sales0.70197.30612.06135.37Price / Cash3.3322.4126.3031.10Price / Book0.725.2912.876.67Net Income-$6.94M$178.04M$3.30B$276.23M7 Day Performance6.38%3.46%4.80%3.31%1 Month Performance-9.32%10.08%8.11%10.76%1 Year Performance-14.71%29.22%75.85%33.58% Integra LifeSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IARTIntegra LifeSciences4.0037 of 5 stars$14.50-2.0%$18.43+27.1%-12.9%$1.15B$1.61B-2.224,396Positive NewsITGRInteger4.0982 of 5 stars$101.06-0.4%$140.25+38.8%-18.5%$3.56B$1.72B44.5211,000Positive NewsATECAlphatec4.4952 of 5 stars$14.75-1.8%$18.50+25.4%+154.3%$2.22B$682.24M-13.05700Positive NewsInsider TradeATRCAtriCure2.4093 of 5 stars$34.87-0.9%$50.89+45.9%+26.0%$1.75B$465.31M-45.291,300OFIXOrthofix Medical2.9271 of 5 stars$14.36+0.5%$21.75+51.5%-4.4%$564.37M$799.49M-4.531,616ANGOAngioDynamics4.07 of 5 stars$10.74+0.6%$19.00+76.9%+90.8%$438.69M$292.50M-12.94760Earnings ReportAnalyst ForecastSRDXSurmodics4.5449 of 5 stars$29.91-0.1%$43.00+43.8%-24.2%$428.07M$126.08M-24.32450Positive NewsARAYAccuray4.494 of 5 stars$1.63-2.4%$5.00+206.7%-11.5%$188.17M$458.51M-81.501,040Gap UpRMTIRockwell Medical3.3037 of 5 stars$1.27flat$4.00+215.0%-66.5%$43.73M$101.49M-21.17300Positive NewsShort Interest ↑ABTAbbott Laboratories4.9577 of 5 stars$133.01-0.4%$145.22+9.2%+19.4%$232.44B$43.11B16.67114,000Positive NewsISRGIntuitive Surgical4.952 of 5 stars$439.22-0.4%$595.95+35.7%-6.1%$158.13B$8.35B61.2615,638Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies ITGR Alternatives ATEC Alternatives ATRC Alternatives OFIX Alternatives ANGO Alternatives SRDX Alternatives ARAY Alternatives RMTI Alternatives ABT Alternatives ISRG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IART) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredIs This Warren’s Buffett’s #1 AI Investment?Did you know that Warren Buffett is investing in what Jeff Brown believes will be the next generation of artif...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
